NYSE · Analyst Forecast

West Pharmaceutical Services, Inc. (WST) Stock Forecast & Price Target

$414.12 NYSE: WST Market Cap $28.85B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering West Pharmaceutical Services, Inc. (WST), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For West Pharmaceutical Services, Inc., analysts forecast revenue rising from $3.06B in 2025 to $4.41B in 2030; the average estimate for 2030 earnings per share is $14.45; with published estimates ranging from $14.07 to $14.83; 12 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$414.12
Consensus targetThe average of the price targets analysts have published.$427.43
Median targetThe middle target, less affected by a single outlier.$425.00
Highest targetThe most optimistic published target.$475.00
Lowest targetThe most pessimistic published target.$390.00
Difference from priceHow far the consensus target sits from today’s price.+3.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$3.00B$3.06B$3.07B11
2026$3.38B$3.42B$3.44B12
2027$3.52B$3.62B$3.71B12
2028$3.78B$3.91B$4.03B12
2029$4.11B$4.19B$4.28B10
2030$4.32B$4.41B$4.50B6

Earnings per share forecast

YearLowAverageHighAnalysts
2025$7.07$7.10$7.1311
2026$8.99$9.49$9.6212
2027$9.51$10.36$10.8212
2028$11.03$11.88$12.7212
2029$13.02$13.37$13.7210
2030$14.07$14.45$14.836

West Pharmaceutical Services, Inc. (WST) forecast — frequently asked questions

What is the analyst price target for West Pharmaceutical Services, Inc.?

Analysts covering West Pharmaceutical Services, Inc. (WST) have a consensus price target of $427.43, 3.2% above the current price of $414.12. Published targets range from $390.00 to $475.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for West Pharmaceutical Services, Inc.'s earnings?

The average analyst estimate for West Pharmaceutical Services, Inc. (WST) earnings per share in 2030 is 14.45, with individual estimates between 14.07 and 14.83.

How much revenue is West Pharmaceutical Services, Inc. expected to make?

Analysts forecast West Pharmaceutical Services, Inc. (WST) revenue of $4.41B in 2030, based on 6 published estimates.

How many analysts cover WST?

12 analysts contribute estimates for West Pharmaceutical Services, Inc. (WST). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Instruments & Supplies stocks

BDX forecastMDLN forecastSOLV forecastBAX forecastCOO forecastRGEN forecastAVTR forecastATR forecastBLCO forecastTFX forecastAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.